Recovery & Tissue Repair Peptides: The Research So Far
Tendon, ligament, and muscle repair all rely on distinct cellular signaling. Here's a breakdown of what the current research covers.
Peptides for Recovery & Tissue Repair
Click on the card to read the full research guide.
BPC-157
The most studied compound in this category, researched for angiogenesis and its proposed role across multiple tissue-repair models.
Read the research guide →TB-500 (Thymosin Beta-4)
Studied for cell migration and its complementary role alongside BPC-157 in repair-focused research.
Read the research guide →GHK-Cu (Copper Peptide)
Researched for wound-healing gene expression and its role in collagen and tissue remodeling.
Read the research guide →IGF-1 LR3
Studied for its role in cell proliferation and growth signaling relevant to muscle and connective-tissue repair.
Read the research guide →Follistatin 344
Researched for its myostatin-inhibiting effects, a pathway studied in the context of muscle-tissue regeneration.
Read the research guide →PEG-MGF (Mechano Growth Factor)
A modified IGF-1 splice variant studied for its localized role in muscle-tissue repair signaling.
Read the research guide →Recovery & Tissue Repair Research Community Discussions
General patterns seen across peptide research forums and discussion boards, not verified outcomes or individual endorsements.
- BPC-157 and TB-500 are almost always discussed together in recovery-focused threads, reflecting how frequently the two are studied as a research pairing.
- GHK-Cu discussion in this category tends to focus on soft-tissue and wound-model research rather than tendon or ligament studies specifically.
- IGF-1 LR3 conversations are often more cautious than other compounds, with contributors flagging the need to separate proliferation research from tissue-quality outcomes.
- Follistatin 344 comes up in more advanced research threads, usually among contributors already familiar with myostatin-pathway literature.
- PEG-MGF discussion is comparatively limited, reflecting its narrower research base relative to other IGF-1 variants.
- A recurring theme across recovery-focused threads: contributors distinguishing early-stage animal or cell-culture findings from anything resembling a confirmed repair timeline.
Safety & Legality
- BPC-157, TB-500, GHK-Cu, IGF-1 LR3, Follistatin 344, and PEG-MGF are sold and discussed here strictly for laboratory research use, not for human consumption.
- None of these compounds are FDA-approved for use in humans, and none of the information on this page constitutes medical advice regarding injury or recovery.
- Research peptide legality varies by country and state. Confirm local regulations before purchasing or importing any compound.
- Always source from suppliers who provide a Certificate of Analysis (COA) for purity and identity testing.
Related Guides
Get New Compound Research, Before It’s Old News
One email when a study, mechanism update, or new compound guide goes live. No spam, unsubscribe anytime.
Research summaries and updates only. We never share your email.